ABSTRACT
Rationale Pulmonary innate immune cells play a central role in the initiation and perpetuation of chronic obstructive pulmonary disease (COPD), however the precise mechanisms that orchestrate the development and severity of COPD are poorly understood.
Objectives We hypothesized that the recently described family of innate lymphoid cells (ILCs) play an important role in COPD.
Methods Subjects with COPD and healthy controls were clinically evaluated, and their sputum samples were assessed by flow cytometry. A mouse model of spontaneous COPD [genetically deficient in surfactant protein-D (SP-D-/-)] and ozone (O3) exposure were used to examine the mechanism by which lack of functional SP-D may skew ILC2s to produce IL-17A in combination with IL-5 and IL-13, leading to a mixed inflammatory profile and more severe disease.
Measurements and Main Results COPD was characterized by poor spirometry, sputum inflammation, and the emergence of sputum GATA3+ ILCs (ILC2s), but not T-bet+ ILCs (ILC1s) nor RORγt+ ILCs (ILC3s). COPD subjects with elevated sputum ILC2s (the ILC2high group) had worse spirometry and sputum neutrophilia and eosinophilia than healthy and ILC2low subjects. This was associated with the presence of dual-positive IL-5+IL-17A+ and IL-13+IL-17A+ ILCs and nonfunctional SP-D in the sputum in ILC2high subjects. SP-D-/- mice showed spontaneous airway neutrophilia. Lack of SP-D in the mouse lung licensed ILC2s to produce IL-17A, which was dose-dependently inhibited by recombinant SP-D. SP-D-/- mice showed enhanced susceptibility to O3-induced airway neutrophilia, which was associated with the emergence of inflammatory IL-13+IL-17A+ ILCs.
Conclusions We report that the presence of sputum ILC2s predicts the severity of COPD, and unravel a novel pathway of IL-17A plasticity in lung ILC2s, prevented by the immunomodulatory protein SP-D.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Tobacco-Related Disease Research Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of University of California, Davis gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Figures and associated figure legends have been updated.
Data Availability
All data produced in the present work are available upon reasonable request to the authors.
ABBREVIATIONS
- COPD
- Chronic Obstructive Pulmonary Disease
- SP-D
- Surfactant Protein-D
- ILC
- Innate Lymphoid Cell
- ILC1
- Group 1 Innate Lymphoid Cell
- ILC2
- Group 2 Innate Lymphoid Cell
- ILC3
- Group 3 Innate Lymphoid Cell
- FEV1
- Forced Expiratory Volume in one second
- FVC
- Forced Vital Capacity
- GOLD
- Global Initiative for Chronic Obstructive Lung Disease
- PFT
- Pulmonary Function Testing
- mMRC
- Modified Medical Research Council scale
- CAT
- COPD Assessment Test
- MP
- Macrophage/monocyte
- LC
- Lymphocyte
- NP
- Neutrophil
- EP
- Eosinophil
- WT
- C57BL/6 Wild-type
- BAL
- Bronchoalveolar Lavage Fluid
- O3
- Ozone
- PBS
- Phosphate-buffed Saline
- rSP-D
- Mouse Recombinant SP-D
- SpO2
- Specific Oxygen